chr20-10412981-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_170784.3(MKKS):​c.534C>T​(p.Ile178=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,613,754 control chromosomes in the GnomAD database, including 14,343 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1772 hom., cov: 32)
Exomes 𝑓: 0.12 ( 12571 hom. )

Consequence

MKKS
NM_170784.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.675
Variant links:
Genes affected
MKKS (HGNC:7108): (MKKS centrosomal shuttling protein) This gene encodes a protein which shares sequence similarity with other members of the type II chaperonin family. The encoded protein is a centrosome-shuttling protein and plays an important role in cytokinesis. This protein also interacts with other type II chaperonin members to form a complex known as the BBSome, which involves ciliary membrane biogenesis. This protein is encoded by a downstream open reading frame (dORF). Several upstream open reading frames (uORFs) have been identified, which repress the translation of the dORF, and two of which can encode small mitochondrial membrane proteins. Mutations in this gene have been observed in patients with Bardet-Biedl syndrome type 6, also known as McKusick-Kaufman syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2023]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-10412981-G-A is Benign according to our data. Variant chr20-10412981-G-A is described in ClinVar as [Benign]. Clinvar id is 21671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-10412981-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.675 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MKKSNM_170784.3 linkuse as main transcriptc.534C>T p.Ile178= synonymous_variant 3/6 ENST00000347364.7 NP_740754.1
MKKSNM_018848.3 linkuse as main transcriptc.534C>T p.Ile178= synonymous_variant 3/6 NP_061336.1
MKKSNR_072977.2 linkuse as main transcriptn.347-4178C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MKKSENST00000347364.7 linkuse as main transcriptc.534C>T p.Ile178= synonymous_variant 3/61 NM_170784.3 ENSP00000246062 P1
MKKSENST00000399054.6 linkuse as main transcriptc.534C>T p.Ile178= synonymous_variant 3/61 ENSP00000382008 P1
MKKSENST00000651692.1 linkuse as main transcriptc.534C>T p.Ile178= synonymous_variant 4/7 ENSP00000498849 P1
MKKSENST00000652676.1 linkuse as main transcriptn.459-281C>T intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21885
AN:
151920
Hom.:
1767
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.151
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.241
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.135
GnomAD3 exomes
AF:
0.140
AC:
35183
AN:
250930
Hom.:
2923
AF XY:
0.143
AC XY:
19463
AN XY:
135632
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.105
Gnomad ASJ exome
AF:
0.0999
Gnomad EAS exome
AF:
0.233
Gnomad SAS exome
AF:
0.247
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.109
Gnomad OTH exome
AF:
0.135
GnomAD4 exome
AF:
0.124
AC:
181619
AN:
1461714
Hom.:
12571
Cov.:
34
AF XY:
0.127
AC XY:
92316
AN XY:
727156
show subpopulations
Gnomad4 AFR exome
AF:
0.195
Gnomad4 AMR exome
AF:
0.109
Gnomad4 ASJ exome
AF:
0.101
Gnomad4 EAS exome
AF:
0.245
Gnomad4 SAS exome
AF:
0.240
Gnomad4 FIN exome
AF:
0.116
Gnomad4 NFE exome
AF:
0.110
Gnomad4 OTH exome
AF:
0.134
GnomAD4 genome
AF:
0.144
AC:
21912
AN:
152040
Hom.:
1772
Cov.:
32
AF XY:
0.150
AC XY:
11134
AN XY:
74322
show subpopulations
Gnomad4 AFR
AF:
0.193
Gnomad4 AMR
AF:
0.151
Gnomad4 ASJ
AF:
0.105
Gnomad4 EAS
AF:
0.241
Gnomad4 SAS
AF:
0.234
Gnomad4 FIN
AF:
0.118
Gnomad4 NFE
AF:
0.107
Gnomad4 OTH
AF:
0.133
Alfa
AF:
0.119
Hom.:
600
Bravo
AF:
0.144
Asia WGS
AF:
0.213
AC:
741
AN:
3478
EpiCase
AF:
0.110
EpiControl
AF:
0.110

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJul 07, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 06, 2015- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedliterature onlyDepartment of Ophthalmology and Visual Sciences Kyoto University-- -
MKKS-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 30, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Bardet-Biedl syndrome;C0948368:McKusick-Kaufman syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
McKusick-Kaufman syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bardet-Biedl syndrome 6 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bardet-Biedl syndrome Benign:1
Benign, no assertion criteria providedcurationGeneReviewsOct 13, 2009- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
1.1
DANN
Benign
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17852625; hg19: chr20-10393629; COSMIC: COSV61398029; COSMIC: COSV61398029; API